ArticleFrontiers in oncology2026
Case Report: Definitive radiotherapy for inoperable anal Buschke-Löwenstein tumors: two cases with literature review.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Buschke-Löwenstein tumors (BLTs), also known as giant condyloma acuminatum, are rare HPV-related lesions with benign histology but locally aggressive behavior, high recurrence rates, and risk of malignant transformation. Complete surgical excision is the standard treatment; however, surgery may be infeasible in advanced, recurrent, or anatomically complex cases. Evidence for radiotherapy as a primary treatment is limited. Case presentation: We report two patients with inoperable anal BLTs treated using modern volumetric-modulated arc therapy (VMAT). Patient 1 received concurrent chemoradiotherapy (30 Gy in 15 fractions) and achieved a marked clinical response with grade 2 acute radiomucositis. Patient 2 underwent definitive radiotherapy alone (45 Gy in 25 fractions) resulting in a partial clinical response at early follow-up, with minimal toxicity. Both treatments were well tolerated. We performed a literature review of published cases of BLTs treated with radiotherapy between 2000 and 2025, which demonstrated heterogeneous treatment approaches but generally favorable clinical responses and acceptable toxicity. Conclusions: Radiotherapy using contemporary VMAT techniques is feasible, safe, and effective for selected patients with inoperable BLTs. When surgery is not possible, radiotherapy alone or combined with chemotherapy may provide early clinical tumor regression with limited toxicity. These findings, combined with existing literature, support consideration of radiotherapy in multidisciplinary management of this rare condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.